Valuation: Alps Group Inc

Market Cap 166M 150M 139M 126M 237M 15.64B 244M 1.67B 663M 8.36B 625M 611M 26.62B P/E 2024
-226x
P/E 2025 -277x
Enterprise Value 173M 156M 144M 131M 247M 16.25B 254M 1.73B 688M 8.69B 649M 635M 27.66B EV / Sales 2024
36.6x
EV / Sales 2025 15.2x
Free-Float
23.35%
Yield 2024 *
-
Yield 2025 -
1 day-25.63%
1 week-25.62%
Current month-26.77%
1 month-35.68%
3 months-41.23%
6 months-71.33%
Current year-72.62%
1 week 1.01
Extreme 1.01000000
2.02
1 month 1.01
Extreme 1.01000000
2.02
Current year 1.01
Extreme 1.01000000
6.95
1 year 1.01
Extreme 1.01000000
8.6
3 years 1.01
Extreme 1.01000000
75
5 years 1.01
Extreme 1.01000000
75
10 years 1.01
Extreme 1.01000000
75
Date Insider Type Main position Quantity % Market Cap. Importance
17/04/26 Other

Director

20,000 0.0120%
18/03/26 Other

Director

150,000 0.0901%
18/03/26 Other

Chief Executive Officer

77,144,380 46.3607%
Change 5-day change 1-year change 3-year change Capi.($)
-25.63%-25.62%-60.45%-97.80% 39.6M
+0.30%+10.40%+11.87%+32.43% 115B
-1.06%-1.34%+5.71%+117.69% 106B
+0.98%-11.22%+54.15%+565.31% 46.38B
+0.64%+2.80%+8.04%+110.94% 33.01B
+0.02%+2.48%+39.97%+82.14% 30.23B
+0.37%+1.93%+38.96%+96.18% 28.46B
-2.09%+0.14%+43.44%+422.80% 23.32B
+0.33%+0.09%-18.10%-16.30% 19.85B
+1.42%+0.77%-5.54%+33.11% 16.77B
Average -2.47%-2.78%+11.81%+134.65% 42B
Weighted average by Cap. -0.05%+1.31%+18.21%+146.64%

Financials

2024 2025
Net sales 2.4M 2.17M 2.01M 1.82M 3.43M 226M 3.53M 24.08M 9.57M 121M 9.02M 8.83M 384M 3.37M 3.05M 2.81M 2.55M 4.81M 317M 4.95M 33.77M 13.42M 169M 12.65M 12.38M 539M
Net income -2.31M -2.09M -1.93M -1.75M -3.3M -217M -3.4M -23.17M -9.21M -116M -8.68M -8.5M -370M -2.51M -2.27M -2.1M -1.9M -3.58M -236M -3.69M -25.18M -10.01M -126M -9.43M -9.23M -402M
Net Debt -1.64M -1.49M -1.37M -1.24M -2.34M -154M -2.41M -16.47M -6.54M -82.59M -6.17M -6.04M -263M 6.49M 5.87M 5.42M 4.9M 9.25M 610M 9.53M 65.04M 25.85M 326M 24.36M 23.84M 1.04B
Projected Income Statement - Annual - Alps Group Inc
Logo Alps Group Inc
Alps Group Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development, medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally. The Company has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The Company provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. It operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.
Employees
-
Date Price Change Volume
11/11/26 $1.190 -25.63% 145,061
10/11/26 $1.600 -3.03% 25,295
09/11/26 $1.650 +0.09% 44,540
06/11/26 $1.649 +4.90% 92,093
05/11/26 $1.572 -1.78% 8,152
  1. Stock Market
  2. Stocks
  3. ALPS Stock